EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,003 | -86.6% | 2,283 | -83.5% | 0.00% | – |
| Q2 2023 | $268,272 | -32.9% | 13,800 | -2.1% | 0.00% | -100.0% |
| Q1 2023 | $399,875 | -5.4% | 14,095 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $422,841 | +11.9% | 14,466 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $378,000 | -41.4% | 14,313 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $645,000 | -9.7% | 14,506 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $714,000 | -10.9% | 14,433 | -8.3% | 0.00% | 0.0% |
| Q4 2021 | $801,000 | -7.4% | 15,738 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $865,000 | +25.4% | 15,504 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $690,000 | +5.3% | 16,131 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $655,000 | -10.4% | 15,702 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $731,000 | +4.7% | 15,702 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $698,000 | -11.5% | 16,440 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $789,000 | +21.9% | 16,440 | +16.9% | 0.00% | 0.0% |
| Q1 2020 | $647,000 | -22.5% | 14,068 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $835,000 | +3.3% | 13,906 | -2.7% | 0.00% | -50.0% |
| Q3 2019 | $808,000 | +1.5% | 14,288 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $796,000 | -2.6% | 14,288 | -11.7% | 0.00% | 0.0% |
| Q1 2019 | $817,000 | +21.9% | 16,178 | -2.7% | 0.00% | 0.0% |
| Q4 2018 | $670,000 | -40.2% | 16,624 | +2.8% | 0.00% | 0.0% |
| Q3 2018 | $1,121,000 | -7.0% | 16,165 | +1.5% | 0.00% | -33.3% |
| Q2 2018 | $1,205,000 | +87.7% | 15,933 | +30.8% | 0.00% | +200.0% |
| Q1 2018 | $642,000 | -7.1% | 12,183 | -5.8% | 0.00% | 0.0% |
| Q4 2017 | $691,000 | -11.6% | 12,933 | -1.4% | 0.00% | -50.0% |
| Q3 2017 | $782,000 | -31.9% | 13,114 | -10.0% | 0.00% | 0.0% |
| Q2 2017 | $1,149,000 | -20.7% | 14,565 | -16.6% | 0.00% | -33.3% |
| Q1 2017 | $1,449,000 | 0.0% | 17,465 | -4.4% | 0.00% | 0.0% |
| Q4 2016 | $1,449,000 | +10.3% | 18,265 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $1,314,000 | +82.5% | 18,765 | +1.1% | 0.00% | +50.0% |
| Q2 2016 | $720,000 | -2.2% | 18,565 | +2.1% | 0.00% | 0.0% |
| Q1 2016 | $736,000 | -47.7% | 18,180 | +14.6% | 0.00% | -33.3% |
| Q4 2015 | $1,407,000 | +21.3% | 15,870 | +1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,160,000 | -8.4% | 15,670 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,267,000 | +1524.4% | 15,670 | +156.9% | 0.00% | – |
| Q1 2014 | $78,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |